Benoît Tessoulin
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 43
- Oncology 49
- CAR-T cell therapy research 25
- Viral-associated cancers and disorders 13
- Co-authors
- Steven Le Gouill (42 shared papers)Philippe Moreau (34 shared papers)Catherine Pellat‐Deceunynck (22 shared papers)Martine Amiot (15 shared papers)David Chiron (21 shared papers)Cyrille Touzeau (25 shared papers)Thomas Gastinne (24 shared papers)Sophie Maïga (9 shared papers)
- Journals
- Blood (18 papers)Blood Advances (8 papers)Annals of Hematology (6 papers)Hematological Oncology (6 papers)Haematologica (6 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Benoît Tessoulin
101 papers receiving 2.3k citations
Benoît Tessoulin's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.1k
- Hematology 468
- Pathology and Forensic Medicine 708
- Genetics 370
- Immunology 298
Countries citing papers authored by Benoît Tessoulin
This map shows the geographic impact of Benoît Tessoulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Tessoulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Tessoulin more than expected).
Fields of papers citing papers by Benoît Tessoulin
This network shows the impact of papers produced by Benoît Tessoulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Tessoulin. The network helps show where Benoît Tessoulin may publish in the future.
Co-authors
The 25 scholars most cited alongside Benoît Tessoulin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma Hit paper breakdown → | 2020 | 318 |
| 2 | 2014 | 143 | |
| 3 | 2020 | 95 | |
| 4 | 2020 | 92 | |
| 5 | 2021 | 81 | |
| 6 | 2016 | 77 | |
| 7 | 2023 | 77 | |
| 8 | 2018 | 67 | |
| 9 | 2019 | 64 | |
| 10 | 2019 | 62 | |
| 11 | 2024 | 55 | |
| 12 | 2018 | 54 | |
| 13 | 2014 | 53 | |
| 14 | 2014 | 52 | |
| 15 | 2019 | 48 | |
| 16 | 2017 | 43 | |
| 17 | 2020 | 42 | |
| 18 | 2018 | 40 | |
| 19 | 2018 | 38 | |
| 20 | CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma Hit paper breakdown → | 2025 | 38 |
About Benoît Tessoulin
Benoît Tessoulin is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Immunology, having authored 110 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), CAR-T cell therapy research (25 papers), Chronic Lymphocytic Leukemia Research (22 papers), Multiple Myeloma Research and Treatments (18 papers), Viral-associated cancers and disorders (13 papers), Hematopoietic Stem Cell Transplantation (9 papers), Protein Degradation and Inhibitors (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Oncology (1.1k citations), Hematology (468 citations), Pathology and Forensic Medicine (708 citations), Genetics (370 citations) and Immunology (298 citations). Benoît Tessoulin has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Steven Le Gouill, Philippe Moreau, Catherine Pellat‐Deceunynck, Martine Amiot, David Chiron, Cyrille Touzeau, Thomas Gastinne, Sophie Maïga, Géraldine Descamps and Céline Bellanger. Their work appears in journals such as Blood, Blood Advances, Annals of Hematology, Hematological Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.